Naziv |
Akcije |
Krečak, Ivan ; Zekanović, Ivan ; Morić Perić, Martina ; Holik, Hrvoje ; Coha, Božena ; Periša, Vlatka ; Lucijanić, Marko
High plateletcrit may be associated with thrombotic risk in polycythemia vera // International journal of laboratory hematology, (2023), doi: 10.1111/ijlh.14073 |
|
(KroHem) Sertić, Zrinka ; Lucijanić, Marko ; Bašić-Kinda, Sandra ; Serventi Seiwerth, Ranka ; Periša, Vlatka ; Sertić, Dubravka ; Coha, Božena ; Pulanić, Dražen ; Perić, Zinaida ; Desnica, Lana et al.
Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem // Biomedicines, 10 (2022), 11; 2892, 11. doi: 10.3390/biomedicines10112892 |
|
Krečak, Ivan ; Holik, Hrvoje ; Morić Perić, Martina ; Zekanović, Ivan ; Coha, Božena ; Lucijanić, Marko
Chronic Kidney Disease has a Higher Prevalence in Polycythemia Vera than in Secondary Polycythemia, a Matched Case–Control Analysis // Indian Journal of Hematology and Blood Transfusion, (2022), doi: 10.1007/s12288-022-01624-z |
|
Galušić, Davor ; Bašić-Kinda, Sandra ; Pijuk, Anđela ; Milunović, Vibor ; Dreta, Barbara ; Franjić, Neven ; Coha, Božena ; Sinčić-Petričević, Jasminka ; Gaćina, Petar ; Pejša, Vlatko et al.
Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases // HemaSphere, 6 (2022), 12; e807, 6. doi: 10.1097/HS9.0000000000000807 |
|
Krečak, Ivan ; Holik, Hrvoje ; Zekanović, Ivan ; Morić Perić, Martina ; Marketin, Tina ; Coha, Božena ; Gverić-Krečak, Velka ; Vodanović, Marijo ; Lucijanić, Marko
Thrombotic risk in secondary polycythemia resembles low-risk polycythemia vera and increases in specific subsets of patients // Thrombosis research, 209 (2022), 47-50. doi: 10.1016/j.thromres.2021.11.025 |
|
Krečak, Ivan ; Holik, Hrvoje ; Morić Perić, Martina ; Zekanović, Ivan ; Coha, Božena ; Gverić-Krečak, Velka ; Lucijanić, Marko
Serum osmolarity in polycythemia vera and its clinical associations // International journal of laboratory hematology, Online ahead of (2022), 1-4. doi: 10.1111/ijlh.13844 |
|
Krečak, Ivan ; Holik, Hrvoje ; Morić Perić, Martina ; Zekanović, Ivan ; Coha, Božena ; Gverić-Krečak, Velka ; Marko, Lucijanić
High platelet-to-lymphocyte ratio may differentiate polycythemia vera from secondary polycythemia // Wiener klinische Wochenschrift, 134 (2022), 11-12; 483-486. doi: 10.1007/s00508-022-02027-w |
|
Krečak, Ivan ; Holik, Hrvoje ; Coha, Božena ; Perić, Martina Morić ; Zekanović, Ivan ; Krečak, Marija Valovičić ; Gverić-Krečak, Velka ; Lucijanić, Marko
Low-density lipoprotein (LDL) and the risk of thrombotic events in essential thrombocythemia and polycythemia vera // Annals of hematology, 100 (2021), 5; 1335-1336. doi: 10.1007/s00277-021-04431-0 |
|
Krečak, Ivan ; Morić Perić, Martina ; Zekanović, Ivan ; Holik, Hrvoje ; Coha, Božena ; Gverić-Krečak, Velka ; Lucijanić, Marko
No impact of the increased number of cardiovascular risk factors on thrombosis and survival in polycythemia vera // Oncology research and treatment, 44 (2021), 4; 201-203. doi: 10.1159/000514347 |
|
Krečak, Ivan ; Zekanović, Ivan ; Holik, Hrvoje ; Morić Perić, Martina ; Coha, Božena ; Gverić‐ Krečak, Velka
Estimating plasma volume using the Strauss‐ derived formula may improve prognostication in polycythemia vera // International journal of laboratory hematology, Online ahead of (2021), https://doi.org/10.1111/ijlh.13716, 3. doi: 10.1111/ijlh.13716 |
|